The impact of genetic polymorphism on course and severity of the SARS-CoV-2 infection and COVID-19 disease
Dawid Wojciulik, Agnieszka Joanna Wasilewska, Karol Adam Kamiński, Anna Moniuszko - Malinowska
Przeglad Epidemiologiczny, doi:10.32394/pe/194862
COVID-19 is severe respiratory and systemic disease with complex pathogenesis and many clinical symptoms, including symptoms from respiratory system, immunology system, cardio-vascular system, haematopoietic system and neurological system. Severe character of the disease is associated with occurrence of respiratory failure, septic shock, multiple organ dysfunctions syndrome, which can lead to patients death due to cardiac arrest. Knowledge about interactions between the virus and human proteins as well as knowledge of immunological mechanisms against infection is a key to identifying the area of virus activity and severity factors of COVID-19. Multiple variants of genes encoding proteins involved in host cell invasion by SARS-CoV-2 virus have been identified: ACE2 and TMPRSS2, TMPRSS11A (HGNC:27954), ELANE (HGNC:3309), CTSL (HGNC:2537), IL-6 rs1800795 variant associated with an increased risk of COVID-19, variant rs35705950:G>T located in the promoter of the MUC5B gene (11p15.5), encoding a protein that plays a key role in maintaining the proper function of the bronchoalveolar epithelium, having a protective effect against the form of the disease requiring hospitalization of the patient, as well as GC rs2282679 gene variant in the vitamin D binding protein associated with a more severe course of COVID-19. 48 of these variants were proved to be directly specific for some populations. Novel techniques of genome analysis enabled the research of the impact of specific polymorphism variants on the severity of various diseases including, COVID-19. Genetic factors analysis can permit understanding of disease pathogenesis, which is a chance to find effective treatment and prevention methods. Collected data from literature indicate that, in the case of COVID-19 disease, there are genes polymorphisms which affect the severity course.
References
Asselta, Paraboschi, Mantovani, Duga, ACE2 and TMPRSS2 variants and expression as candidates to sex and country differences in COVID-19 severity in Italy, Aging
Atal, IL-6 Inhibitors in the Treatment of Serious COVID-19: A Promising Therapy?, Pharmaceut Med
Baillie, Wain, Jenkins, Feenstra, Shared genetic etiology between idiopathic pulmonary fibrosis and COVID-19 severity, EBioMedicine
Baktash, Hosack, Patel, Shah, Kandiah et al., Vitamin D status and outcomes for hospitalised older patients with COVID-19, Postgrad Med J
Banu, Panikar, Leal, Leal, Protective role of ACE2 and its downregulation in SARS-CoV-2 infection leading to Macrophage Activation Syndrome: Therapeutic implications, Life Sci
Beyerstedt, Casaro, Rangel, COVID-19: angiotensin-converting enzyme 2 (ACE2) expression and tissue susceptibility to SARS-CoV-2 infection, Eur J Clin Microbiol Infect Dis
Bosso, Thanaraj, Abu-Farha, Alanbaei, Abubaker et al., The Two Faces of ACE2: The Role of ACE2 Receptor and Its Polymorphisms in Hypertension and COVID-19, Mol Ther Methods Clin Dev
Brull, Montgomery, Sanders, Dhamrait, Luong et al., Interleukin-6 gene -174G > C and -572G > C promoter polymorphisms are strong predictors of plasma interleukin-6 levels after coronary artery bypass surgery, Arterioscler Thromb Vasc Biol
Castillo, Costa, Barrios, Díaz, Miranda et al., Effect of calcifediol treatment and best available therapy versus best available therapy on intensive care unit admission and mortality among patients hospitalized for COVID-19: A pilot randomized clinical study, J Steroid Biochem Mol Biol
Charoenngam, Shirvani, Reddy, Vodopivec, Apovian et al., Association of Vitamin D Status With Hospital Morbidity and Mortality in Adult Hospitalized Patients With COVID-19, EndocrPract
Chen, Zhao, Qu, Chen, Xiong et al., Detectable Serum Severe Acute Respiratory Syndrome Coronavirus 2 Viral Load (RNAemia) Is Closely Correlated With Drastically Elevated Interleukin 6 Level in Critically Ill Patients With Coronavirus Disease 2019, Clin Infect Dis
Chun, New perspectives on the vitamin D binding protein, Cell Biochem Funct
David, Parkinson, Peacock, Pairo-Castineira, Khanna et al., A common TMPRSS2 variant has a protective effect against severe COVID-19, Curr Res Transl Med
Delanghe, Speeckaert, Speeckaert, Behind the scenes of vitamin D binding protein: more than vitamin D binding, Best Pract Res Clin Endocrinol Metab
Doyle, Casselbrant, Hs, Doyle, Lo et al., The interleukin 6 -174 C/C genotype predicts greater rhinovirus illness, J Infect Dis
Driggin, Madhavan, Bikdeli, Chuich, Laracy et al., Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the COVID-19 Pandemic, J Am Coll Cardiol
Du, Tu, Zhu, Mu, Wang et al., Clinical Features of 85 Fatal Cases of COVID-19 from Wuhan. A Retrospective Observational Study, Am J Respir Crit Care Med
Duarte, Carvalheiro, Rodrigues, Dias, Marques et al., Prevalence of vitamin D deficiency and its predictors in the Portuguese population: a nationwide population-based study, Arch Osteoporos
Elnagdy, Magdy, Eldars, Elgamal, El-Nagdy et al., Genetic association of ACE2 and TMPRSS2 polymorphisms with COVID-19 severity; a single centre study from Egypt, Virol J
Evans, Fingerlin, Schwarz, Lynch, Kurche et al., Idiopathic pulmonary fibrosis: a genetic disease that involves mucociliary dysfunction of the peripheral airways, Physiol Rev
Fadista, Kraven, Karjalainen, Andrews, Geller, COVID-19 Host Genetics Initiative
Freitas, Calhau, Antunes, Araújo, Bandeira et al., Vitamin D-related polymorphisms and vitamin D levels as risk biomarkers of COVID-19 disease severity, Sci Rep
Gkogkou, Barnasas, Vougas, Trougakos, Expression profiling meta-analysis of ACE2 and TMPRSS2, the putative anti-inflammatory receptor and priming protease of SARS-CoV-2 in human cells, and identification of putative modulators, Redox Biol
González, Ayala-Ramírez, Gelvez, Suarez-Obando, Ariza et al., Epigenetic mechanisms and host factors impact ACE2 gene expression: Implications in COVID-19 susceptibility, Infect Genet Evol
Gupta, Kaur, Pathak, Banerjee, Systematic review and meta-analysis of human genetic variants contributing to COVID-19 susceptibility and severity, Gene
Hamet, Pausova, Attaoua, Hishmih, Haloui et al., SARS-CoV-2 Receptor ACE2 Gene Is Associated with Hypertension and Severity of COVID 19: Interaction with Sex, Obesity, and Smoking, Am J Hypertens
Hetta, Muhammad, El-Masry, Taha, Ahmed et al., The interplay between vitamin D and COVID-19: protective or bystander?, Eur Rev Med. Pharmacol Sci
Hoffmann, Kleine-Weber, Schroeder, Krüger, Herrler et al., SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor, Cell
Huang, Wang, Li, Ren, Zhao et al., Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China, Lancet
Kaidashev, Izmailova, Shlykova, Kabaliei, Vatsenko et al., Polymorphism of tmprss2 (rs12329760) but not ace2 (rs4240157), tmprss11a (rs353163) and cd147 (rs8259) is associated with the severity of COVID-19 in the Ukrainian population, Acta Biomed
Kerget, Kerget, Frequency of interleukin-6 rs1800795 (-174G/C) and rs1800797 (-597G/A) polymorphisms in COVID-19 patients in Turkey who develop macrophage activation syndrome, Jpn J Infect Dis
Kew, The Vitamin D Binding Protein and Inflammatory Injury: A Mediator or Sentinel of Tissue Damage?, Front Endocrinol
Liu, Zhou, Zhou, Wu, Zhao et al., Risk factors associated with disease severity and length of hospital stay in COVID-19 patients, J Infect
Maria, Latini, Borgiani, Novelli, Genetic variants of the human host influencing the coronavirus-associated phenotypes (SARS, MERS and COVID-19): rapid systematic review and field synopsis, Hum Genomics
Meier, Gressner, Lammert, Gressner, Gc-globulin: roles in response to injury, Clin Chem
Millet, Whittaker, Host cell proteases: Critical determinants of coronavirus tropism and pathogenesis, Virus Res
Monticelli, Hay Mele, Benetti, Fallerini, Baldassarri et al., Gen-Covid Multicenter Study. Protective Role of a TMPRSS2 Variant on Severe COVID-19 Outcome in Young Males and Elderly Women, Genes
Nakano, Yang, Walts, Watson, Helling et al., MUC5B promoter variant rs35705950 affects MUC5B expression in the distal airways in idiopathic pulmonary fibrosis, Am J Respir Crit Care Med
Otterbein, Cosio, Graceffa, Dominguez, Crystal structures of the vitamin D-binding protein and its complex with actin: structural basis of the actin-scavenger system, Proc Natl Acad Sci U S A
Pal, Banerjee, Bhadada, Shetty, Singh et al., Vitamin D supplementation and clinical outcomes in COVID-19: a systematic review and meta-analysis, J Endocrinol Invest
Patel, Nair, Revai, Grady, Saeed et al., Association of proinflammatory cytokine gene polymorphisms with susceptibility to otitis media, Pediatrics
Peljto, Zhang, Fingerlin, Ma, Garcia et al., Association between the MUC5B promoter polymorphism and survival in patients with idiopathic pulmonary fibrosis, JAMA
Revai, Patel, Grady, Nair, Matalon et al., Association between cytokine gene polymorphisms and risk for upper respiratory tract infection and acute otitis media, Clin Infect Dis
Rose, Voynow, Respiratory tract mucin genes and mucin glycoproteins in health and disease, Physiol Rev
Samy, Gaber, Amer, El-Deeb, Abdelmoaty et al., Role of ACE2 and TMPRSS2 polymorphisms in clinical severity and outcomes of COVID-19 in Egypt, Afr J Lab Med
Sanderson, Kumari, Brunner, Miller, Rumley et al., Association between IL6 gene variants -174G>C and -572G>C and serum IL-6 levels: Interactions with social position in the Whitehall II cohort, Atherosclerosis
Seibold, Smith, Urbanek, Groshong, Cosgrove et al., The idiopathic pulmonary fibrosis honeycomb cyst contains a mucocilary pseudostratified epithelium, PLoS One
Seibold, Wise, Speer, Steele, Brown et al., A common MUC5B promoter polymorphism and pulmonary fibrosis, N Engl J Med
Slominski, Stefan, Athar, Holick, Jetten et al., COVID-19 and Vitamin D: A lesson from the skin, Exp Dermatol
Soraya, Ulhaq, Crucial laboratory parameters in COVID-19 diagnosis and prognosis: An updated meta-analysis, Med Clin (Barc)
Terpos, Ntanasis-Stathopoulos, Elalamy, Kastritis, Sergentanis et al., Hematological findings and complications of COVID-19, Am J Hematol
Tikellis, Bernardi, Burns, Angiotensinconverting enzyme 2 is a key modulator of the renin-angiotensin system in cardiovascular and renal disease, Curr Opin Nephrol Hypertens
Trougakos, Stamatelopoulos, Terpos, Tsitsilonis, Aivalioti et al., Insights to SARS-CoV-2 life cycle, pathophysiology, and rationalized treatments that target COVID-19 clinical complications, J Biomed Sci
Ulhaq, Soraya, Anti-IL-6 receptor antibody treatment for severe COVID-19 and the potential implication of IL-6 gene polymorphisms in novel coronavirus pneumonia, Med Clin
Ulhaq, Soraya, Interleukin-6 as a potential biomarker of COVID-19 progression, Med Mal Infect
Varga, Flammer, Steiger, Haberecker, Andermatt et al., Endothelial cell infection and endotheliitis in COVID-19, Lancet
Vargas-Alarcón, Posadas-Sánchez, Bello, Variability in genes related to SARS-CoV-2 entry into host cells (ACE2, TMPRSS2, TMPRSS11A, ELANE, and CTSL) and its potential use in association studies, Life Sci
Verma, Minnier, Wan, Huffman, Gao et al., Million Veteran Program COVID-19 Science Initiative. A MUC5B Gene Polymorphism, rs35705950-T, Confers Protective Effects Against COVID-19 Hospitalization but Not Severe Disease or Mortality, Am J Respir Crit Care Med
Wood, Bassford, Webster, Newby, Rajesh et al., Vitamin D-binding protein contributes to COPD by activation of alveolar macrophages, Thorax
Wu, Li, Wang, Zhang, Qiao, The ACE2 G8790A Polymorphism: Involvement in Type 2 Diabetes Mellitus Combined with Cerebral Stroke, J Clin Lab Anal
Yaghoobi, Lord, Rezaiezadeh, Yekaninejad, Amini et al., TMPRSS2 polymorphism (rs12329760) and the severity of the COVID-19 in Iranian population, PLoS One
Yang, Xie, Tu, Fu, Xu et al., The signal pathways and treatment of cytokine storm in COVID-19, Signal Transduct Target Ther
Zhang, Bastard, Liu, Pen, Velez et al., Inborn errors of type I IFN immunity in patients with lifethreatening COVID-19, Science
Zoń-Giebel, Giebel, Review article. Macrophage activation syndrome -a reactive haemophagocytic lymphohistiocytosis, Rheumatology
{ 'indexed': { 'date-parts': [[2024, 10, 31]],
'date-time': '2024-10-31T18:40:24Z',
'timestamp': 1730400024167,
'version': '3.28.0'},
'reference-count': 0,
'publisher': 'National Institute of Public Health NIH (National Research Institute)',
'license': [ { 'start': { 'date-parts': [[2024, 10, 31]],
'date-time': '2024-10-31T00:00:00Z',
'timestamp': 1730332800000},
'content-version': 'vor',
'delay-in-days': 0,
'URL': 'https://creativecommons.org/licenses/by-nc/4.0/'},
{ 'start': { 'date-parts': [[2024, 10, 31]],
'date-time': '2024-10-31T00:00:00Z',
'timestamp': 1730332800000},
'content-version': 'am',
'delay-in-days': 0,
'URL': 'https://creativecommons.org/licenses/by-nc/4.0/'},
{ 'start': { 'date-parts': [[2024, 10, 31]],
'date-time': '2024-10-31T00:00:00Z',
'timestamp': 1730332800000},
'content-version': 'tdm',
'delay-in-days': 0,
'URL': 'https://creativecommons.org/licenses/by-nc/4.0/'}],
'content-domain': {'domain': [], 'crossmark-restriction': False},
'abstract': '<jats:p>COVID-19 is severe respiratory and systemic disease with complex pathogenesis and '
'many clinical symptoms, including symptoms from respiratory system, immunology system, '
'cardio-vascular system, haematopoietic system and neurological system. Severe character of '
'the disease is associated with occurrence of respiratory failure, septic shock, multiple '
'organ dysfunctions syndrome, which can lead to patients death due to cardiac arrest.\n'
'Knowledge about interactions between the virus and human proteins as well as knowledge of '
'immunological mechanisms against infection is a key to identifying the area of virus activity '
'and severity factors of COVID-19. Multiple variants of genes encoding proteins involved in '
'host cell invasion by SARS-CoV-2 virus have been identified: ACE2 i TMPRSS2, TMPRSS11A '
'(HGNC:27954), ELANE (HGNC:3309) oraz CTSL (HGNC:2537), IL-6 rs1800795 variant associated with '
'an increased risk of COVID-19, variant rs35705950:G>T located in the promoter of the MUC5B '
'gene (11p15.5), encoding a protein that plays a key role in maintaining the proper function '
'of the bronchoalveolar epithelium, having a protective effect against the form of the disease '
'requiring hospitalization of the patient, as well as GC rs2282679 gene variant in the vitamin '
'D binding protein associated with a more severe course of COVID-19. 48 of these variants were '
'proved to be directly specific for some populations.\n'
'Novel techniques of genome analysis enabled the research of the impact of specific '
'polymorphism variants on the severity of various diseases including, COVID-19. Genetic '
'factors analysis can permit understanding of disease pathogenesis, which is a chance to find '
'effective treatment and prevention methods. Collected data from literature indicate that, in '
'the case of COVID-19 disease, there are genes polymorphisms which affect the severity '
'course.</jats:p>',
'DOI': '10.32394/pe/194862',
'type': 'journal-article',
'created': { 'date-parts': [[2024, 10, 31]],
'date-time': '2024-10-31T18:02:17Z',
'timestamp': 1730397737000},
'source': 'Crossref',
'is-referenced-by-count': 0,
'title': 'The impact of genetic polymorphism on course and severity of the SARS-CoV-2 infection and '
'COVID-19 disease',
'prefix': '10.32394',
'author': [ {'given': 'Dawid', 'family': 'Wojciulik', 'sequence': 'first', 'affiliation': []},
{ 'given': 'Agnieszka Joanna',
'family': 'Wasilewska',
'sequence': 'additional',
'affiliation': []},
{'given': 'Karol Adam', 'family': 'Kamiński', 'sequence': 'additional', 'affiliation': []},
{ 'given': 'Anna',
'family': 'Moniuszko - Malinowska',
'sequence': 'additional',
'affiliation': []}],
'member': '17323',
'published-online': {'date-parts': [[2024, 10, 31]]},
'container-title': 'Przeglad Epidemiologiczny',
'original-title': [ 'Wpływ polimorfizmu genetycznego na przebieg oraz ciężkość zakażenia wirusem '
'SARS-CoV-2 oraz choroby COVID-19'],
'link': [ { 'URL': 'https://www.przeglepidemiol.pzh.gov.pl/pdf-194862-115927',
'content-type': 'application/pdf',
'content-version': 'vor',
'intended-application': 'text-mining'},
{ 'URL': 'https://www.przeglepidemiol.pzh.gov.pl/pdf-194862-115927',
'content-type': 'unspecified',
'content-version': 'vor',
'intended-application': 'similarity-checking'}],
'deposited': { 'date-parts': [[2024, 10, 31]],
'date-time': '2024-10-31T18:02:18Z',
'timestamp': 1730397738000},
'score': 1,
'resource': { 'primary': { 'URL': 'https://www.przeglepidemiol.pzh.gov.pl/Wplyw-polimorfizmu-genetycznego-na-przebieg-oraz-ciezkosc-zakazenia-wirusem-SARS,194862,0,2.html'}},
'subtitle': [],
'short-title': [],
'issued': {'date-parts': [[2024, 10, 31]]},
'references-count': 0,
'alternative-id': ['194862'],
'URL': 'http://dx.doi.org/10.32394/pe/194862',
'relation': {},
'ISSN': ['0033-2100', '2545-1898'],
'subject': [],
'container-title-short': 'Przegl Epidemiol',
'published': {'date-parts': [[2024, 10, 31]]}}
